Welcome to our dedicated page for Aesthetic Medical International Holdings Group Ltd. American Depositary Shares SEC filings (Ticker: AIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Want to know how Aesthetic Medical International Holdings Group Ltd.—better known as AIH—monetizes its chain of aesthetic clinics? Investors who ask “where can I read the AIH quarterly earnings report 10-Q filing” or “AIH insider trading Form 4 transactions” usually start here. Stock Titan gathers every disclosure straight from EDGAR and delivers AI-powered summaries that turn dense prose into clear numbers, trends and risk factors, so you can understand AIH SEC filings explained simply in minutes instead of hours.
Each document—whether an AIH annual report 10-K simplified, an AIH 8-K material events explained notice, or a AIH proxy statement executive compensation update—is tagged, searchable and paired with AIH earnings report filing analysis from our models. Use real-time alerts to follow AIH Form 4 insider transactions real-time and catch AIH executive stock transactions Form 4 before the market reacts. Interactive tables allow you to compare segment revenue, same-clinic growth and cash flow data across multiple periods without scrolling through hundreds of pages.
Whether you monitor cosmetic surgery capacity, assess regulatory risks of cross-border operations, or benchmark expansion costs, our platform makes understanding AIH SEC documents with AI straightforward. Download spreadsheets, share custom notes with your team, and rely on timely push notifications when a fresh AIH 8-K hits the wire. From insider buying signals to shifts in procedure mix, Stock Titan equips you with the context needed to make informed decisions—no jargon, no delay, just actionable detail drawn directly from the source.
Aesthetic Medical International reported operational shifts in the first half of 2025: total treatment cases fell by 2.3% year‑on‑year following reduced advertising spend, while the mix moved toward non‑surgical aesthetic procedures, which rose by 3.6 percentage points as a share of total treatments. Average spending per customer declined 1.2%, from RMB1,099 to RMB1,086, driven by increased promotional activity such as discounted live‑stream e‑commerce offers. The disclosure includes references to standard financial line items and balance sheet headings but lacks complete numeric tables or full financial results in the provided extract.
FAQ
What is the current stock price of Aesthetic Medical International Holdings Group Ltd. American Depositary Shares (AIH)?
What is the market cap of Aesthetic Medical International Holdings Group Ltd. American Depositary Shares (AIH)?
